Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Nursing | Oncology | Surgery | News

Back to Health News

Radiation Plus Chemo a Good Option in Lung Cancer

Last Updated: July 27, 2009.

 

Surgery alone not linked to improved survival in non-small-cell lung cancer study

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Surgery alone not linked to improved survival in non-small-cell lung cancer study.

MONDAY, July 27 (HealthDay News) -- Radiotherapy plus chemotherapy, with or without surgery, works well for people with stage 3A non-small-cell lung cancer, a new study has found.

Stage 3A is declared when surgery cannot cure the disease because it has spread to the lymph nodes in the center of the chest.

Non-small-cell lung cancer accounts for about 80 percent of lung cancers, and smoking tobacco is the most common cause of lung cancer. According to the U.S. National Cancer Institute, the risk of lung cancer is linked to the earlier in life a person starts smoking, the more often a person smokes and the more years a person smokes.

For the study, a research team led by Dr. Kathy Albain of Loyola University Chicago Stritch School of Medicine in Maywood, Ill., compared 202 patients who underwent chemotherapy plus radiotherapy followed by surgery with 194 patients who underwent chemotherapy plus radiotherapy alone, which is the current standard for these patients.

The researchers looked at the overall survival rates of the 396 patients after five years to draw their conclusions. They found no statistically significant difference in overall survival.

In an exploratory analysis, the researchers found that overall survival did improve for patients who only had part of a lung removed (lobectomy) rather than an entire lung. They speculated that removing an entire lung left patients more likely to die from acute respiratory distress syndrome or other respiratory diseases.

"On the basis of the findings of our study, patients should be counseled about the risks and potential benefits of definitive chemotherapy plus radiotherapy with, and without, a surgical resection (preferably by lobectomy)," the authors concluded.

The findings appear in the July 27 online edition of The Lancet.

More information

Learn more about non-small-cell lung cancer from the U.S. National Cancer Institute.

SOURCE: The Lancet, news release, July 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: With Autism, Diet Restrictions May Do More Harm Than Good Next: Marriage Ends, Health Declines

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.